Öztürk Mehmet Hayrullah, Kerkez Müjde, Kılıç Serap Parlar
Department of Medical Services and Techniques, Health Services Vocational School, Sırnak Universitey, Şırnak, Turkey.
Department of Nursing, Faculty of Health Sciences, Şırnak University, Şırnak, Turkey.
J Diabetes Metab Disord. 2025 Jun 5;24(1):140. doi: 10.1007/s40200-025-01652-2. eCollection 2025 Jun.
This study was conducted in order to evaluate the effect of insulin administration training provided to patients with Type 2 diabetes mellitus who use insulin on their safe medication usage, pain levels, and treatment perception.
A randomized controlled trial was designed. This study was conducted with a total of 84 patients (43 in the experimental group and 41 in the control group) diagnosed with Type 2 diabetes who were admitted to a public hospital in the Southeastern Anatolia Region of Turkey between October 2022 and March 2023. The patient information form, Insulin Administration Skill Observation Form, Visual Analog Scale, and Insulin Treatment Appraisal Scale were used. The experimental group was provided with individualized training and a booklet on the use of insulin.
Both posttest and retention test measurements were taken after the insulin administration training. According to these measurements, insulin administration skill and insulin treatment perceptions of the experimental group were significantly higher than those of the control group, while their pain intensity score was significantly lower ( < 0.001).
The results of this study revealed that the insulin administration training increased safe medication application and insulin treatment perceptions of the patients in the experimental group and lowered their pain levels.
ClinicalTrials.gov = NCT05915338.
本研究旨在评估对使用胰岛素的2型糖尿病患者进行胰岛素注射培训,对其安全用药、疼痛程度及治疗认知的影响。
设计了一项随机对照试验。本研究共纳入84例2022年10月至2023年3月期间入住土耳其安纳托利亚东南部地区一家公立医院的2型糖尿病患者(试验组43例,对照组41例)。使用了患者信息表、胰岛素注射技能观察表、视觉模拟量表和胰岛素治疗评估量表。试验组接受了胰岛素使用的个性化培训及一本手册。
胰岛素注射培训后进行了后测和留存测试。根据这些测量结果,试验组的胰岛素注射技能和胰岛素治疗认知显著高于对照组,而其疼痛强度评分显著更低(<0.001)。
本研究结果表明,胰岛素注射培训提高了试验组患者的安全用药及胰岛素治疗认知,并降低了他们的疼痛程度。
ClinicalTrials.gov = NCT05915338